ISRCTN95396292Completed未知
Simultaneous Administration of Lorazepam and Levetiracetam in nonconvulsive Status Epilepticus, followed by intravenous valproate
Z Leuven (Belgium)0 sites80 target enrollmentStarted: April 30, 2008Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 80
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •1. Adult male and female patients
- •2. Nonconvulsive SE (NCSE), and more specifically, complex partial SE (CPSE) and SE in coma. NCSE is defined as a change in behaviour and/or mental status from baseline associated with electroencephalogram (EEG) changes consistent with SE. We subdivide CPSE into i) CPSE in patients with epilepsy and ii) CPSE de novo. We consider subtle SE as a subgroup of SE in coma. Subtle SE is defined as SE that evolved from convulsive seizures to seizures with minor motor manifestations, such as muscle twitches, tonic eye deviation and nystagmoid eye jerks, and ictal EEG changes.
Exclusion Criteria
- •1. Postanoxic myoclonus or myoclonic status epilepticus
- •2. Organic or psychogenic pseudoseizures
- •3. Coma with the following EEG patterns:
- •3.1. Periodic lateralised epileptiform discharges (PLEDs)
- •3.2. Bilateral independent periodic lateralised epileptiform discharges (BiPLEDs)
- •3.3. Periodic epileptiform discharges (PEDs)
- •3.4. Generalized periodic epileptiform discharges
- •3.5. Stimulus-induced rhythmic periodic ictal-like discharges (SIRPIDs)
- •3.6. Triphasic waves
- •4. Cases that are doubtful on electroclinical grounds, in whom a diagnosis of SE would only be made a posteriori after a therapeutic trial with anti-epileptic drugs
- •5. Current treatment with levetiracetam
- •6. Contraindications for administration of valproic acid (VPA), such as hepatitis, mitochondrial disease, pancreatitis, pregnancy and hepatic porphyria
- •Note: The following are not part of the exclusion criteria:
- •1. Prior treatment for seizures
- •2. Renal failure
Investigators
Similar Trials
Active, not recruiting
Phase 1
Simultaneous administration of lorazepam and levetiracetam in non-convulsive status epilepticus, followed by IV valproate: a prospective, randomized, placebo-controled, double-blind pilot trial. - SALLISSEon-convulsive status epilepticusEUCTR2008-001098-13-BEZ Leuven80
Completed
Phase 4
The effectiveness of Ibuprofen and Lorazepam combination therapy in treating the symptoms of acute migraineEthics Committee Branch of Tonekabon Islamic Azad University has approved the study design. Participation in the study is voluntary. Each of the study participants were able to recognize and feel themMigraine,Acute,Treatment,Ibuprofen,LorazepamTCTR20160927003Azad Islamic University90
Completed
Phase 2
orazepam effect on reducing nausea and vomitingHyperemesis gravidarum.Hyperemesis gravidarum with metabolic disturbanceIRCT2014051917742N2Vice chancellor for research Ahvaz Jundishapur University of Medical Sciences76
Completed
Phase 2
The efficacy of combination of Olanzapine, Aprepitant, Palonosetron and dexamethasone for the prevention of nausea and vomiting in patients receiving autologous peripheral blood stem cell transplantation for multiple myelomamultiple myelomaJPRN-UMIN000035970Hitachi general hospital52
Completed
Phase 3
Treatment of vomiting in breast cancer patientsCTRI/2017/12/010864Mysore medical college ad research institute